Live Analyst Rating Changes 1525 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Kevin Kopelman
TD
Kevin Kopelman
TD Cowen
Wall Street Analyst
★★★☆☆
#1040
on 13Foresight · ranked by our own returns
58%
Success Rate
+4.0%
Average Return
11 of 19 calls profitable · -382.5% vs benchmark
🔒 5-year track record is Pro. Showing 1-year — upgrade.
📈 Across the calls we could measure, roughly 58% of Kevin Kopelman's ratings turned a profit when each position was held for 1 year — averaging +4.0% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

55 Buy 10 Hold 0 Sell
Kevin's Stock Coverage 19 ratings · 2026-06-20
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return
CCL
Carnival
 Jun 12, 2026 BUY Strong Buy
+5.3% avg upside
34 analysts
$38.00
23.03% Upside
 +5.8%
NCLH
Norwegian Cruise Line
 May 15, 2026 BUY Buy
+13.6% avg upside
30 analysts
$22.00
7.55% Upside
 +33.3%
RCL
Royal Caribbean
 May 15, 2026 BUY Strong Buy
-8.2% avg upside
31 analysts
$337.00
7.78% Upside
 +20.7%
ABNB
Airbnb
 May 08, 2026 BUY Buy
+13.0% avg upside
53 analysts
$170.00
19.30% Upside
 -0.7%
EXPE
Expedia
 May 08, 2026 HOLD Buy
-4.7% avg upside
51 analysts
$285.00
18.31% Upside
 +4.3%
H
Hyatt Hotels
 Apr 30, 2026 HOLD Buy
-23.5% avg upside
32 analysts
$175.00
13.37% Downside
 -1.9%
BKNG
Booking Holdings
 Apr 29, 2026 BUY Strong Buy
+530.4% avg upside
54 analysts
$230.00
33.92% Upside
 -1.1%
HLT
Hilton Worldwide Holdings
 Apr 22, 2026 BUY Buy
-23.1% avg upside
34 analysts
$390.00
11.76% Upside
 +4.7%
MAR
Marriott International
 Apr 22, 2026 BUY Buy
-19.6% avg upside
34 analysts
$410.00
3.50% Upside
 +7.7%
TCOM
Trip.com Group Sponsored ADR
 Feb 26, 2026 BUY Strong Buy
+45.8% avg upside
30 analysts
$68.00
50.73% Upside
 -11.1%
TRIP
TripAdvisor
 Jan 23, 2025 HOLD Hold
+97.0% avg upside
42 analysts
$20.00
54.28% Upside
 -26.2%
TRVG
trivago
 Oct 25, 2018 HOLD Hold
-3.6% avg upside
15 analysts
$5.00
7.45% Upside
 -41.3%
ANGI
Angi
 Jan 17, 2017 HOLD Buy
+123.5% avg upside
28 analysts
$6.50
29.50% Upside
 +75.6%
GRPN
Groupon
 Oct 14, 2016 SELL Hold
-6.2% avg upside
29 analysts
$4.00
75.21% Downside
 +7.6%
TRUP
Trupanion
 Oct 13, 2016 BUY Strong Buy
+73.6% avg upside
19 analysts
$17.00
27.85% Downside
 ·
YELP
Yelp
 Sep 27, 2016 HOLD Buy
+64.8% avg upside
49 analysts
$38.00
66.08% Upside
 +2.5%
CMPR
Cimpress
 May 26, 2016 HOLD Buy
-4.3% avg upside
8 analysts
$90.00
6.07% Upside
 -8.9%
EHTH
Ehealth
 Oct 24, 2013 BUY Hold
+864.7% avg upside
19 analysts
$45.00
2627.26% Upside
 -45.6%
AMZN
Amazon
 Jul 27, 2012 BUY Strong Buy
+208.7% avg upside
107 analysts
 — +31.5%
🔒 14 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Kevin Kopelman — Frequently Asked Questions
How accurate are Kevin Kopelman's stock ratings?
Based on the calls 13Foresight could measure, about 58% of Kevin's ratings were profitable over a one-year hold, with an average return of +4.0% per rating, or -5.8% versus the S&P 500. We score every analyst the same way, from historical prices.
How is Kevin ranked on 13Foresight?
Kevin Kopelman is currently ranked #1040 with a 3-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Kevin cover?
Kevin most recently has ratings on CCL, NCLH, RCL, ABNB, EXPE, H, BKNG, HLT, MAR, TCOM, TRIP, TRVG and 7 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.